Comprehensive Control of Human Papillomavirus Infections and Related Diseases
| Autor: | Steve Schwartz, Christina Jensen, Charles J.N. Lacey, Henry C Kitchener, Ian N. Hampson, Johannes Berkhof, Isabelle Heard, Lawrence Banks, Ginesa Albero, Connie Trimble, Myriam Chevarie-Davis, Wim Quint, Thomas R. Broker, Christine Bergeron, Xavier Castellsagué, Maria Brotons, Pierre Van Damme, Martyn Plummer, Laia Alemany, D. Scott LaMontagne, Jane J. Kim, Joel M. Palefsky, Vivien Tsu, F. Xavier Bosch, Jack Cuzick, Anna R. Giuliano, George Koliopoulos, Jose Jeronimo, Rengaswamy Sankaranarayanan, Freddie Bray, Heather Cubie, Marc T. Goodman, William A. Fisher, Mark Schiffman, Karen Canfell, Mireia Diaz, Catherine de Martel, Silvia de Sanjosé, Gina Ogilvie, Peter J.F. Snijders, Philip E. Castle, Julian Peto, Anil K. Chaturvedi, Scott Wittet, Chris J.L.M. Meijer, Lynette Denny, Jerome L. Belinson, Boŝtjan J. Kocjan, Beatriz Serrano, John T. Schiller, Ann N. Burchell, Anne Szarewski, Eduardo Lazcano-Ponce, Shelley L. Deeks, Walter Kinney, David Forman, Ligia A. Pinto, Joannie Lortet-Tieulent, Guglielmo Ronco, Joakim Dillner, Thomas Iftner, Bettie M. Steinberg, Marc Steben, Susanne K. Kjaer, Anna-Barbara Moscicki, Patti E. Gravitt, Attila T. Lorincz, Marc Arbyn, Peter L. Stern, Mario Poljak, Ahti Anttila, John Doorbar, Isabelle Soerjomataram, Ignacio G. Bravo, Eduardo L. Franco, Jacques Ferlay, Magnus von Knebel Doeberitz, You-Lin Qiao, Alex Vorsters, Pontus Naucler, Silvia Franceschi, Alison Nina Fiander, Andrea Vicari, Maura L. Gillison, Harrell W. Chesson, Suzanne M. Garland, Laia Bruni, Sjoerd H. van der Burg, Susan A. Wang, Shalini L Kulasingam, Sandra D. Isidean, Mark A. Kane, Jérôme Vignat, Mark H. Einstein, Julia M.L. Brotherton, Jennifer S. Smith, Mark H. Stoler, Margaret Stanley, Lauri E. Markowitz |
|---|---|
| Přispěvatelé: | ICO Monograph 'Comprehensive Contr, ICO Monograph Comprehensive, Pathology, CCA - Oncogenesis, ICO Monograph 'Comprehensive Conto, ICO Monograph Comprehensive Control of HPV Infections and Related Diseases |
| Rok vydání: | 2013 |
| Předmět: |
Male
and promotion of well-being Uterine Cervical Neoplasms Comorbidity Disease Global Health Cervical Cancer Medical and Health Sciences 0302 clinical medicine Health care Global health Medicine 030212 general & internal medicine Early Detection of Cancer Cancer Vaginal cancer Cervical cancer Oropharyngeal cancer 0303 health sciences Vulvar Neoplasms Vulvar cancer Vaccination HPV infection Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30 Biological Sciences Anus Neoplasms Supplement 5 female genital diseases and pregnancy complications 3. Good health Oropharyngeal Neoplasms Infectious Diseases 3.4 Vaccines 030220 oncology & carcinogenesis Screening HIV/AIDS Molecular Medicine Female Infection HPV testing HPV medicine.medical_specialty Vaginal Neoplasms Papillomaviruses 030231 tropical medicine HPV vaccines Article Vaccine Related Papillomavirus Vaccines 03 medical and health sciences Comorbiditat Clinical Research Virology Humans Anal cancer Human papillomavirus Papil·lomavirus Cancer Control Survivorship and Outcomes Research - Health Services Economic and Health Policy Analyses Penile Neoplasms 030304 developmental biology HPV vaccination Agricultural and Veterinary Sciences General Veterinary General Immunology and Microbiology authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30 business.industry Prevention Papillomavirus Infections Public Health Environmental and Occupational Health Penile cancer Prevention of disease and conditions medicine.disease Good Health and Well Being Family medicine Immunology Sexually Transmitted Infections Immunization Human medicine HPV and/or Cervical Cancer Vaccines business Cancer Type - Cervical Cancer |
| Zdroj: | Vaccine; Vol 31 Vaccine Bosch, F X, Broker, TR, Forman, D, Moscicki, A B, Gillison, M L, Doorbar, J, Stern, P L, Stanley, M, Arbyn, M, Poljak, M, Cuzick, J, Castle, P E, Schiller, J T, Markowitz, L E, Fisher, W A, Canfell, K, Denny, L A, Franco, E L, Steben, M, Kane, M A, Schiffman, M, Meijer, C J L M, Sankaranarayanan, R, Castellsague, X, Kim, J J, Brotons, M, Alemany, L, Albero, G, Diaz, M & de Sanjose, S 2013, ' Comprehensive control of human papillomavirus infections and related diseases ', Vaccine, vol. 31, no. Suppl 7, pp. H1-H31 . https://doi.org/10.1016/j.vaccine.2013.07.026 Vaccine, vol 31 Suppl 7, iss Suppl 7 Vaccine, vol 31 Suppl 8, iss 0 8 Vaccine, 31(Suppl 7), H1-H31. Elsevier BV Recercat. Dipósit de la Recerca de Catalunya instname Dipòsit Digital de la UB Universidad de Barcelona |
| ISSN: | 0264-410X |
| Popis: | Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a causal etiology with HPV has been stated by the International Agency for Research on Cancer for cancers of the cervix uteri, penis, vulva, vagina, anus and oropharynx (including base of the tongue and tonsils). Of the estimated 12.7 million new cancers occurring in 2008 worldwide, 4.8% were attributable to HPV infection, with substantially higher incidence and mortality rates seen in developing versus developed countries. In recent years, we have gained tremendous knowledge about HPVs and their interactions with host cells, tissues and the immune system; have validated and implemented strategies for safe and efficacious prophylactic vaccination against HPV infections; have developed increasingly sensitive and specific molecular diagnostic tools for HPV detection for use in cervical cancer screening; and have substantially increased global awareness of HPV and its many associated diseases in women, men, and children. While these achievements exemplify the success of biomedical research in generating important public health interventions, they also generate new and daunting challenges: costs of HPV prevention and medical care, the implementation of what is technically possible, socio-political resistance to prevention opportunities, and the very wide ranges of national economic capabilities and health care systems. Gains and challenges faced in the quest for comprehensive control of HPV infection and HPV-related cancers and other disease are summarized in this review. The information presented may be viewed in terms of a reframed paradigm of prevention of cervical cancer and other HPV-related diseases that will include strategic combinations of at least four major components: 1) routine introduction of HPV vaccines to women in all countries, 2) extension and simplification of existing screening programs using HPV-based technology, 3) extension of adapted screening programs to developing populations, and 4) consideration of the broader spectrum of cancers and other diseases preventable by HPV vaccination in women, as well as in men. Despite the huge advances already achieved, there must be ongoing efforts including international advocacy to achieve widespread-optimally universal-implementation of HPV prevention strategies in both developed and developing countries. This article summarizes information from the chapters presented in a special ICO Monograph 'Comprehensive Control of HPV Infections and Related Diseases' Vaccine Volume 30, Supplement 5, 2012. Additional details on each subtopic and full information regarding the supporting literature references may be found in the original chapters. (C) 2013 Elsevier Ltd. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect